IIM
TMCI icon

INTECH Investment Management’s Treace Medical Concepts TMCI Stock Holding History

INTECH Investment Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,959
Closed -$17.4K – 2272
2026
Q1 		$17.4K Sell
12,959
-9,611
-43% -$19.2K ﹤0.01% 2072
2025
Q4 		$55.3K Buy
22,570
+2,722
+14% +$11.8K ﹤0.01% 2252
2025
Q3 		$133K Sell
19,848
-5,379
-21% -$35.1K ﹤0.01% 2182
2025
Q2 		$148K Hold
25,227
– – ﹤0.01% 2192
2025
Q1 		$212K Buy
25,227
+9,860
+64% +$88.6K ﹤0.01% 2063
2024
Q4 		$114K Sell
15,367
-4,950
-24% -$33.1K ﹤0.01% 2185
2024
Q3 		$118K Buy
+20,317
New +$130K ﹤0.01% 1857

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

INTECH Investment Management's TMCI Position: Q2 2026 in Review

INTECH Investment Management sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 12,959 shares — an estimated $17.4K sold.

INTECH Investment Management first reported a position in TMCI in Q3 2024 and held it in 7 quarters. The position peaked at $212K in Q1 2025. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • INTECH Investment Management reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • INTECH Investment Management sold 12,959 Treace Medical Concepts shares in Q2 2026, an estimated $17.4K.
  • INTECH Investment Management first reported a position in Treace Medical Concepts in Q3 2024 and held it in 7 quarters.
  • INTECH Investment Management's Treace Medical Concepts position peaked at $212K in Q1 2025.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.